Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "2022"

1485 News Found

Expectations and predictions for 2022
Opinion | December 28, 2021

Expectations and predictions for 2022

In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc


2022: Predictions for medical and healthcare industry
Opinion | December 20, 2021

2022: Predictions for medical and healthcare industry

2022 is going to be the year of opportunities and innovations from the medical industry in India


Most national diagnostic players to deliver double-digit revenue growth in FY2022: ICRA
News | December 15, 2021

Most national diagnostic players to deliver double-digit revenue growth in FY2022: ICRA

During H1 FY2022, the revenues and operating profit margin (OPM) for ICRA sample set showed sharp improvement aided by volume uptick in Covid-19 and allied tests and also demand traction for non-Covid tests


KOREA PACK and ICPI to be held in June 2022 in hybrid format
Packaging | December 13, 2021

KOREA PACK and ICPI to be held in June 2022 in hybrid format

KOREA PACK and concurrent event ICPI Week (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022


QMS Medical targets Rs. 500 crore revenue by FY29
Healthcare | June 23, 2026

QMS Medical targets Rs. 500 crore revenue by FY29

The company reported consolidated revenue of Rs. 172.9 crore and EBITDA of Rs 25.9 crore in FY26


We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
interviews | June 16, 2026

We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene

Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships


ResMed acquires Noctrix Health for $340 million
Medical Device | June 04, 2026

ResMed acquires Noctrix Health for $340 million

Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio


Ardena appoints Ariane de Ganck as Chief Scientific Officer
People | June 01, 2026

Ardena appoints Ariane de Ganck as Chief Scientific Officer

Ariane brings a strong track record within Ardena, including her leadership of the company’s drug product division since 2022


India’s MedTech industry is entering its defining decade: Dr. Shravan Subramanyam, MD, BPL Medical Technologies
Opinion | May 29, 2026

India’s MedTech industry is entering its defining decade: Dr. Shravan Subramanyam, MD, BPL Medical Technologies

From import dependence to global leadership, the next phase of growth must be driven not only by manufacturing scale and policy support, but also by innovation, research, and globally competitive healthcare technologies


India’s healthcare spending triples to Rs 3.85 lakh crore over the last decade
Policy | May 28, 2026

India’s healthcare spending triples to Rs 3.85 lakh crore over the last decade

As per National Health Accounts (NHA) estimates, government health expenditure rose steadily between 2013-14 and 2022-23, while out-of-pocket spending declined significantly